Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
16.86
-0.41 (-2.35%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Tandem Diabetes Care Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$44.44
Upside
+163.66%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Hold Initiates $20 | Hold | Initiates | $20 | +18.66% | Apr 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $45 → $22 | Buy → Hold | Downgrades | $45 → $22 | +30.53% | Mar 5, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $35 → $24 | Strong Buy → Hold | Downgrades | $35 → $24 | +42.39% | Mar 4, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $42 → $24 | Hold | Maintains | $42 → $24 | +42.39% | Mar 3, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $38 → $22 | Buy → Hold | Downgrades | $38 → $22 | +30.53% | Mar 3, 2025 |
| Barclays | Barclays | Buy Maintains $60 → $53 | Buy | Maintains | $60 → $53 | +214.45% | Feb 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +226.31% | Feb 27, 2025 |
| Baird | Baird | Hold Maintains $37 → $33 | Hold | Maintains | $37 → $33 | +95.79% | Feb 27, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $63 | Strong Buy | Maintains | $63 | +273.78% | Feb 26, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $57 → $50 | Strong Buy | Maintains | $57 → $50 | +196.65% | Dec 11, 2024 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $45 | Hold → Buy | Upgrades | $45 | +166.98% | Dec 2, 2024 |
| Barclays | Barclays | Buy Maintains $58 → $60 | Buy | Maintains | $58 → $60 | +255.98% | Nov 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $57 → $56 | Strong Buy | Maintains | $57 → $56 | +232.25% | Nov 7, 2024 |
| Baird | Baird | Hold Maintains $39 → $37 | Hold | Maintains | $39 → $37 | +119.52% | Nov 7, 2024 |
| Bernstein | Bernstein | Buy Initiates $42 | Buy | Initiates | $42 | +149.18% | Nov 6, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $46 | Hold | Initiates | $46 | +172.92% | Oct 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.